ConferenceSeries Ltd is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth “9thAnnual Pharmaceutical Analysis Congress” (Pharma Analysis 2017) scheduled to be held during October 02-03, 2017 at Vienna, Austria. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharma Analysis and Clinical Trials.

ConferenceSeries Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

2017 Highlights:

  • 300+ Participation (70 Industry: 30 Academia)

  • 5+ Keynote Speakers

  • 50+ Plenary Speakers

  • 20+ Exhibitors

  • 14 Innovative Educational Sessions

  • 5+ Workshops

Theme: Innovations in Pharmaceutical Analysis and Quality

The global pharmaceutical excipients market is projected to reach USD 8.1 Billion in 2021 at a CAGR of 6.1% in the forecast period 2016 to 2021. The rising demand for new drug delivery systems, greater understanding of the functional benefits of excipients, growing pharmaceutical industry, and patent expiries of several blockbuster drugs are positively impacting the overall growth of the market.The global particle size analysis market over the forecast period of 2017 to 2021. The market is expected to reach USD 256.1 Million by 2021, at CAGR of 4.7% from 2017 to 2021. Increasing nanotechnology research, presence of stringent regulatory guidelines to ensure compliance with GMP guidelines, and growing efforts by players to expand their geographic presence are driving the growth of the particle size analysis market during the forecast period.Analysis software market is expected to reach USD 3,135.3 Million by 2020 from USD 2,143.7 Million in 2017, at a CAGR of 7.9% from 2017 to 2020.

The global single-cell analysis market is expected to reach USD 3.35 Billion by 2021 from USD 1.45 Billion in 2017 at a CAGR of 18.2%. The global market is broadly classified into product, cell type, technique, application, end-users, and regions.Many of these materials are not compatible with body tissues and fluids and can cause complications such as infections and blood clots. According to the Centers for Disease Control and Prevention (CDC), around 2,000,000 patients contract hospital-acquired infections (HAIs) every year in the U.S., resulting in 100,000 deaths; HAIs cost the U.S. healthcare system an estimated USD 45 billion annually.

Scope and Importance:

Pharmaceutical analysis services to support development programs (R&D), regulatory submissions, GMP manufacturing and post-marketing requirements. Pharmaceutical analysis plays an important role in both the development process and GMP manufacturing. Concerns about drug safety, costly development programs, complex manufacturing, market demands for evidence-based data and increased regulatory requirements are all issues that can be addressed through a better understanding of your drug substance, drug product or manufacturing process which, in turn, can only be achieved through experienced analytical studies and robust analytical data. 

Call for paperSubmit paper

Topics of submission

Track 1:Pharmaceutical Development and Technology

Track 1-1Nanotechnology for enhancing bioavailability

Track 1-2Biopharmaceutics and Pharmacokinetics

Track 1-3Optimization techniques

Track 1-4Methodological advancements in pharmaceutical industries

Track 1-5Novel drug target approaches

Track 1-6Recent advances in medical devices

Track 2:Advances and applications in HPLC Techniques

Track 2-1 Hyphenated HPLC methods

Track 2-2 Adsorption chromatography

Track 2-3Chip based separations

Track 2-4Ion exchange chromatography

Track 2-5Separation techniques in chemistry

Track 2-6Novel techniques in chromatography

Track 3:Regulatory Affairs

Track 3-1Career development in regulatory affairs

Track 3-2Regulatory strategies and developments

Track 3-3Regulatory communications and submissions

Track 3-4Regulatory challenges for medical devices

Track 3-5Regulatory requirements for pharmaceuticals

Track 3-6Biologics and Biosimilars

Track 4:Quality Control, Quality Assurance and Regulatory Filings

Track 4-1Quality control in pharmaceutical labs

Track 4-2Current regulations and quality Standards

Track 4-3 The role of quality impact assessment and effectiveness checks

Track 4-4Contract and sterile/aseptic manufacturing

Track 4-5Storage, distribution, and transportation

Track 4-6Formulation development

Track 4-7Industrial pharmacy

Track 5:Pharmaceutical Methods and Innovations in Pharma Engineering

Track 5-1Regulatory Requirements for Pharmaceuticals

Track 5-2Medico Marketing & Digital Pharma

Track 5-3Generics and Biologics

Track 5-4Pharma and Biotech Financial Outlook

Track 5-5R&D Advancement and Development

Track 5-6Clinical Pharmacy and Therapeutics

Track 5-7Pharmaceutical Sciences

Track 6:Pharmaceutical Nanotechnology

Track 6-1Pre-formulation and formulation aspects

Track 6-2Pharmacokinetics and pharmacodynamics in drugs

Track 6-3Drug targeting and design

Track 6-4Nanotechnology in drug delivery

Track 6-5Smart Drug Delivery Systems

Track 6-6Biomaterials in Drug Delivery

Track 6-7Vaccine drug delivery systems

Track 6-8Medical Devices for Drug Delivery

Track 6-9Peptides and protein drug delivery

Track 7:Chromatography

Track 7-1Adsorption chromatography

Track 7-2Advancement and application in chromatography

Track 7-3Special techniques in chromatography

Track 7-4High performance liquid chromatography

Track 7-5Gas chromatography

Track 7-6Affinity chromatography

Track 7-7Separation techniques in chemistry

Track 7-8Ion exchange chromatography

Track 7-9Partition chromatography

Track 7-10Novel techniques in chromatography

Track 8:Drug Formulation & Drug Design Pre-Formulation

Track 8-1Novel drug delivery system

Track 8-2Computer aided drug designing (CADD)

Track 8-3Drug targeting and rational drug design

Track 8-4Pharmacokinetics and pharmacodynamics in drugs

Track 8-5Analytical method development and validation

Track 8-6Drug product manufacturing

Track 8-7Shelf life and stability studies

Track 8-8Role of API in research and development

Track 8-9Drug evolution process of IND, NDA & ANDA

Track 8-10Bio markers in drug designing

Track 9:Bioavailability and Bioequivalence

Track 9-1Clinical trials

Track 9-2Contract research organizations

Track 9-3Challenges in drug design and drug development

Track 9-4Bioavailability and bioequivalence studies

Track 9-5Nutrient bioavailability

Track 9-6Advances in BA and BE

Track 10:Separation Processes in Chemical Manufacturing Industries.

Track 10-1Membrane technology in separation processes

Track 10-2Novel separation techniques in chemistry

Track 10-3Emerging separation technologies

Track 10-4Advancements in sample preparation techniques

Track 10-5Chromatography as a separation technique

Track 10-6Hyphenated techniques

Track 10-7Applications of separation techniques

Track 11:Spectroscopy in Pharmaceutical Analysis

Track 11-1Applications and innovations in mass spectrometry

Track 11-2Spectrometry in proteomics

Track 11-3Recent advances and development in spectrometry

Track 11-4Mass spectrometry imaging

Track 11-5Fundamentals of spectrometry

Track 11-6Ionization techniques

Track 11-7Spectrometry configurations and sample preparation techniques

Track 11-8Chromatography and high performance liquid chromatography (HPLC)

Track 12:Design and Analysis in Chemical Research

Track 12-1Pharmacological research chemicals in the context of drug law avoidance

Track 12-2Processes of discovering and devising new pharmacotherapy

Track 12-3Design and analysis in chemical research and development

Track 12-4Chemists in research and development laboratories

Track 12-5Relationship between regression coefficients in LVR and MLR

Track 13:Aqueous and Non-Aqueous Titrimetric Method

Track 13-1Physical and chemical characteristic of the drug molecule

Track 13-2Lowry and bronsted’s theory

Track 13-3Analysis of liquid and solid dosage forms

Track 13-4Effects of temperature on assay

Track 13-5Protogenic and Amphiprotic solvents

Track 14:Errors in Pharmaceutical Analysis

Track 14-1Procedure for sampling techniques

Track 14-2Validation of pharmaceutical analysis

Track 14-3Determinate or systematic error

Track 14-4Indeterminate or random error

Track 14-5Basic calculation in pharmaceutical analysis

Track 15:Determine The Accuracy and Precision of Drug

Track 15-1Parameters of validation

Track 15-2Purity and management of pharma analysis

Track 15-3Pharmaceutical chemical management

Track 15-4Linearity and Range

Track 16:Modern Pharmaceutical Analysis

Track 16-1Documentation of pharma industry

Track 16-2Regulation of the quality of analytical methods

Track 16-3Biological respond and chemical purity

Track 16-4Thermo analytical analysis

Track 16-5High performance liquid chromatography

Track 17:Limit Test for Quantitative Analysis

Track 17-1Stabilty of drug dosade form

Track 17-2Tests for arsenic

Track 17-3Tests for chloride

Track 17-4Quantitative determinations

Track 18:Degradation and Impurity Analysis of Different Dosage Forms

Track 18-1Weak bases in mixed aqueous and non-aqueous media

Track 18-2Qualitative and quantitative analysis

Track 18-3Enantiomeric impurities

Track 18-4Organic volatile impurities

Track 18-5Signal impurities

Track 19:Absorption, Distribution, Metabolism and Elimination

Track 19-1Bio availability of drug based on drug efficacy

Track 19-2Non-alcoholic fatty liver disease (NAFLD)

Track 19-3Genome-wide mRNA levels in samples

Track 19-4Role of pharmaceutical analysis in ADME

Track 20:Assay Methods Based on Separation Techniques

Track 20-1Liquid-liqid extraction

Track 20-2Thin layer chromatography

Track 20-3Gas liquid chromatography

Track 20-4Size exclusion chromatography

Track 20-5Distribution co-efficient


Leave a message


Contact information